Adverum Biotechnologies Inc (ADVM)
5.80
+0.05
(+0.87%)
USD |
NASDAQ |
Nov 22, 10:18
Adverum Biotechnologies Price: 5.80 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 6.11 | 6.16 | 5.70 | 5.75 | 873634.0 |
| Nov 20, 2024 | 6.26 | 6.34 | 6.00 | 6.17 | 221481.0 |
| Nov 19, 2024 | 6.86 | 6.90 | 6.14 | 6.25 | 623105.0 |
| Nov 18, 2024 | 7.30 | 7.729 | 6.85 | 6.85 | 413132.0 |
| Nov 15, 2024 | 7.29 | 7.29 | 6.81 | 6.86 | 233912.0 |
| Nov 14, 2024 | 7.64 | 7.64 | 7.225 | 7.25 | 204388.0 |
| Nov 13, 2024 | 7.90 | 8.05 | 7.53 | 7.56 | 124399.0 |
| Nov 12, 2024 | 7.79 | 7.97 | 7.59 | 7.89 | 202229.0 |
| Nov 11, 2024 | 8.18 | 8.18 | 7.75 | 7.76 | 147086.0 |
| Nov 08, 2024 | 7.91 | 8.06 | 7.83 | 8.00 | 126243.0 |
| Nov 07, 2024 | 7.98 | 8.12 | 7.87 | 7.90 | 110736.0 |
| Nov 06, 2024 | 8.02 | 8.08 | 7.76 | 7.94 | 187679.0 |
| Nov 05, 2024 | 7.53 | 7.767 | 7.26 | 7.72 | 104786.0 |
| Nov 04, 2024 | 7.49 | 7.73 | 7.295 | 7.54 | 127563.0 |
| Nov 01, 2024 | 7.32 | 7.505 | 7.17 | 7.41 | 175843.0 |
| Oct 31, 2024 | 7.90 | 7.90 | 7.29 | 7.295 | 130288.0 |
| Oct 30, 2024 | 7.74 | 8.07 | 7.711 | 7.88 | 187501.0 |
| Oct 29, 2024 | 7.96 | 8.01 | 7.62 | 7.76 | 171035.0 |
| Oct 28, 2024 | 8.02 | 8.20 | 7.86 | 7.92 | 235538.0 |
| Oct 25, 2024 | 8.21 | 8.21 | 7.90 | 7.98 | 92368.00 |
| Oct 24, 2024 | 8.17 | 8.27 | 8.03 | 8.08 | 97137.00 |
| Oct 23, 2024 | 8.02 | 8.27 | 7.90 | 8.12 | 142661.0 |
| Oct 22, 2024 | 8.28 | 8.33 | 8.08 | 8.14 | 183046.0 |
| Oct 21, 2024 | 8.44 | 8.53 | 8.18 | 8.26 | 211367.0 |
| Oct 18, 2024 | 8.08 | 8.56 | 8.02 | 8.48 | 166708.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.40
Minimum
Dec 27 2022
256.40
Maximum
Jun 23 2020
47.91
Average
16.06
Median
Mar 22 2024
Price Benchmarks
| EyePoint Pharmaceuticals Inc | 8.59 |
| Cassava Sciences Inc | 27.12 |
| Regenxbio Inc | 9.36 |
| Editas Medicine Inc | 2.45 |
| Apellis Pharmaceuticals Inc | 28.89 |
Price Related Metrics
| Price to Book Value | 0.8372 |
| Earnings Yield | -103.6% |
| Market Cap | 120.65M |